Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arko Corp. (ARKO) vs Mesoblast Limited (MESO) Price & Performance

Arko Corp.Trade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Arko Corp. vs Mesoblast Limited — how do they compare? Arko Corp. trades at $4.39 (market cap $493.06M), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: Mesoblast Limited is far larger — about 4.5× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

ARKOMESO
Market Cap
$493.06M$2.21B
Sector
Consumer CyclicalTechnology
52-Week High
$8.64$20.96
52-Week Low
$3.82$12.88
Enterprise Value
$2.67B$2.21B
Dividend Yield
2.73%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arko Corp.

ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

Read more on ARKO

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO